lecture 19 - anticoagulants
TRANSCRIPT
-
8/14/2019 Lecture 19 - Anticoagulants
1/43
%&%$
%#%$
%!%%#&$
-
8/14/2019 Lecture 19 - Anticoagulants
2/43
,02489,88 8 90 ,77089 41 -44/ 488 1742 ,
/,2,0/ ;0880 %8 :8:, 3;4;08
, 4.,0/ ;,84.43897.943
- 5,9009 ,/0843 ,3/ ,.9;,943
. -44/ .4,:,943
-
8/14/2019 Lecture 19 - Anticoagulants
3/43
$06:03.041;03983420489,88
-
8/14/2019 Lecture 19 - Anticoagulants
4/43
%0 1472,943 41 ,3 :3,390/ .49 93
90 -44/ ;08808 8 90 2489 .42243
,-3472,9 41 420489,88
-
8/14/2019 Lecture 19 - Anticoagulants
5/43
7907, 9742-488 2, 708:9
3 8.02. 30.7488 41 90 988:0 8:550/
- 90 ,7907
3 0,250 8 24.,7/, 31,7.943 /:0
94 4..:843 41 90 .4743,7 ,790708
-
8/14/2019 Lecture 19 - Anticoagulants
6/43
'034:8 9742-488 2, .,:80 988:08
/7,30/ - 90 ;03 94 -0.420 0/02,94:8
,3/ 31,20/
-
8/14/2019 Lecture 19 - Anticoagulants
7/43
%$
%0 .4,:,943 574.088 9,9 0307,908
9742-3 .438898 41 94 390770,90/ 5,9,8
, 09738. 5,9,
- 39738. 5,9,
-
8/14/2019 Lecture 19 - Anticoagulants
8/43
%009738.88902 839,90/-90
,.9;,94341.49931,.947'
,3/90700,8041988:09742-45,893 ,
548545/,3/57490329:70
-
8/14/2019 Lecture 19 - Anticoagulants
9/43
%039738.88902 897070/03-44/
.42083.439,.9905480/.4,03
1-7083908:-03/490:241/,2,0/
-44/;08808
-
8/14/2019 Lecture 19 - Anticoagulants
10/43
39738.5,9, 9738.5,9,
,
,
,
,
!
,
'
,
,
!
'
,
', '
422435,9,
!749742-31,.947 %742-3
,-73403 -73
$9,-01-7354207
-
8/14/2019 Lecture 19 - Anticoagulants
11/43
49889028,.9;,901,.94797,3814723
939490,.9;01472,.903
.43;07985749742-33949742-3
%013,89053905,9,890
.43;07843-1,.947,411-734033941-73
-
8/14/2019 Lecture 19 - Anticoagulants
12/43
%&%$
%4 9508 41 /7:8 ,70 02540/ 3
570;0393 -44/ .4,:,943 05,73 ,3/
90 ;9,23 ,39,43898
%07 20.,3828 41 ,.943
/1107 ,8 /4 907 .3., :808
-
8/14/2019 Lecture 19 - Anticoagulants
13/43
/4+62
05,73 8 , 7,5/ ,.93 ,39.4,:,39
05,73 4..:78 3472, .42500/ 94
89,230 3 2,89 .08
9 8 89743 ,./.
-
8/14/2019 Lecture 19 - Anticoagulants
14/43
/-+27 30 -832
05,73 3.70,808 ,.9;9 41 ,399742-3
. 3-98 ,.9;,90/ 80730 57490,808
8:. ,8 , 9742-3 , , , ,
,3/ , 3 90 .4993 .,8.,/0
-
8/14/2019 Lecture 19 - Anticoagulants
15/43
05,73 14728 , 9073,7 .4250 9
,399742-3 ,3/ 90 .4993 1,.9478
%0 .4993 1,.9478 ,70 3,.9;,90/ ,3/
05,73 8 700,80/ 1742 90 .4250
-
8/14/2019 Lecture 19 - Anticoagulants
16/43
05,73 ,84 ,8 , /70.9 ,39.4,:,39
,.9;9 ,8 /0243897,90/ - 98 0110.9;03088
3 ;974
05,73 700,808 54574903 5,80 1742
;,8.:,7 -0/8 ,..007,908 .0,73 41
545749038 1742 90 5,82,
-
8/14/2019 Lecture 19 - Anticoagulants
17/43
%0,39.4,:,390110.94105,738
220/,90,3/2,2,,39.4,:,943
4..:789323:908,1907/70.9397,;034:8
05,7330.943
-
8/14/2019 Lecture 19 - Anticoagulants
18/43
$/6+4/98- 97/7
5704507,9;0 5745,8 ,,389 /005
;03 9742-488
3 ,.:90 24.,7/, 31,7.943
94 570;039 5:243,7 02-482 3 5,90398
9 089,-80/ 9742-488
94 570;039 .4993 3 097,.475470,
.7.:,943 /0;.08
-
8/14/2019 Lecture 19 - Anticoagulants
19/43
05,73 .,3 -0 ;03 0907 ,8 , .4393:4:8
31:843 47 - 3907299039 30.9438
9 .,3 ,84 -0 ;03 ,8 /005 8:-.:9,304:8
30.9438
-
8/14/2019 Lecture 19 - Anticoagulants
20/43
05,73 8 9,03 :5 - 90 709.:403/490,
88902 ,3/ :3/07408 05,9. /07,/,943
94 3,.9;0 574/:.98
%0701470 9 ,8 , 4307 ,110 3 5,90398
9 05,9. .77488
-
8/14/2019 Lecture 19 - Anticoagulants
21/43
.:/67//00/-87
, 00/3.425.,943802477,0.,3
-0.439740/-;35749,2308:5,90
,-,8.8:-89,3.0!749,230-3/89994
,3/30:97,0890,39.4,:,39
0110.94105,73
-
8/14/2019 Lecture 19 - Anticoagulants
22/43
.:/67//00/-87-328.
- 50780389;970,.943810;07,3,5,8
. %742-4.94503,
/ 89045474889439072970,92039
-
8/14/2019 Lecture 19 - Anticoagulants
23/43
'+60+62
,71,73 8 , .4:2,73 /07;,9;0
34907 0,250 8 /.4:2,74
%080 ,39.4,:,398 ,.9 - ,39,433
'9 . 8 088039, 147 90 839088
41 , 3:2-07 41 .4993 1,.9478 3.:/3
,.9478 '
-
8/14/2019 Lecture 19 - Anticoagulants
24/43
&30 05,73 90 ,39.4,:,39 0110.9 41
,71,73 ,3/ 70,90/ .4254:3/8 ,70 349
4-807;0/ :39 4:78 ,1907
/7: ,/23897,943
-
8/14/2019 Lecture 19 - Anticoagulants
25/43
,71,73 8 47, ,.9;0 -4,;,,-9 8
,1907 47, ,/23897,943
9 8 09038;0 -4:3/ 94 5,82, 5749038
,3/ .,3 /85,.0 2,3 4907 /7:8 1742
98 890
-
8/14/2019 Lecture 19 - Anticoagulants
26/43
.:/67/ /00/-87
-00/3
02477,. 31,7.943 3 90 -70,89
3908930 ,3/ 1,99 988:08
-
8/14/2019 Lecture 19 - Anticoagulants
27/43
,71,73 70,/ .748808 90 5,.039, ,3/
.,3 .,:80 02477,0 3 90 109:8
9 8 90701470 .4397, 3/.,90/ 3 5703,3.
-
8/14/2019 Lecture 19 - Anticoagulants
28/43
691 28/6+-8327
9070 ,70 , 3:2-07 41 /7:8 9,9 549039,90
90 ,39.4,:,39 0110.9 41 ,7,1,73 8:. ,8
,.:90 ,.44 394.,943 .209/30
503-:9,430 0 49078 ,9903:,90
90 ,39.4,:,39 0110.9 41 ,7,1,73
8:. ,8 .743. ,.44 308943
-,7-9:7,908 71,25.3
-
8/14/2019 Lecture 19 - Anticoagulants
29/43
$"$ "%#
-73 .498 ,70 /884;0/ - 90 0320
5,823
3 ;;4 3,.9;0 5,823403 8 .43;0790/ 94
5,823 - 988:0 5,823403 ,.9;,947
9!
-
8/14/2019 Lecture 19 - Anticoagulants
30/43
.:90 9742-402-4. /80,80 2, -0
970,90/ - 90 ,/23897,943 41 ,0398 9,9
,.9;,90 90 .43;07843 41 5,823403 94
5,823 , 80730 57490,80 9,9 /74808
1-73 ,3/ 9:8 /884;08 .498
,2508$9705943,80 :743,80 ,3/
988:0 950 5,823403 ,.9;,947 9!
-
8/14/2019 Lecture 19 - Anticoagulants
31/43
#86/4832+7/
$9705943,80 8 ,3 097,.0:,7 574903
/07;0/ 1742 8970594.4..
-
8/14/2019 Lecture 19 - Anticoagulants
32/43
/-+27 30 +-832
9 -3/8 94 5,823403 ,3/ .,9,08 90
.43;07843 41 5,823403 94 ,.9;0 5,823
9 ,.98 43 -49 1-73-4:3/ ,3/
.7.:,93 5,823403
-
8/14/2019 Lecture 19 - Anticoagulants
33/43
$/6+4/98- 97/7
3 ,.:90 5:243,7 02-482 /005 ;03
9742-488 ,.:90 24.,7/, 31,7.943
,7907, 9742-488 ,3/ 4..:/0/
507507, ,790708
-
8/14/2019 Lecture 19 - Anticoagulants
34/43
+6+-32/8-
$9705943,80 907,5 8 3899:90/ 93
4:78 41 , 24.,7/, 31,7.943 ,3/
.4393:0/ 147 94 /,8
.:/67/ /00/-87
, 00/3 /847/078
- 50780389;9
-
8/14/2019 Lecture 19 - Anticoagulants
35/43
%632+7/
9 ,8 473, 4-9,30/ 1742 :730 -:9
8 34 4-9,30/ 1742 .:9:70/ /30 .08
/-+27 30 +-832
,9,08 90 .43;07843 41 5,823403
94 5,823 9 ,.98 43 -49 1-73-4:3/ ,3/
.7.:,93 5,823403
-
8/14/2019 Lecture 19 - Anticoagulants
36/43
$/6+4/98- 97/7
3 ,.:90 5:243,7 02-482 /005 ;03
9742-488 ,.:90 24.,7/, 31,7.943
,7907, 9742-488 ,3/ 4..:/0/
507507, ,790708
9 8 :801: 3 5,90398 80389;0 94
89705943,80
-
8/14/2019 Lecture 19 - Anticoagulants
37/43
.:/67/ /00/-87
00/3 .425.,9438 ,70 90 2489
25479,39 8/0 0110.98
-
8/14/2019 Lecture 19 - Anticoagulants
38/43
$779/ 84/ +7231/2 +-8:+836
9 8 ,3 03/4034:8 57490,80
/-+27 30 +-832
9! 7,5/ ,3/ 570107039, ,.9;,908
1-73-4:3/ 5,823403
9 ,8 , 847907 ,110 9,3 89705943,80
,3/ :743,80 0,/3 94 290/ 88902.
,/;0780 0110.98
-
8/14/2019 Lecture 19 - Anticoagulants
39/43
$/6+4/98- 97/7
4.,7/, 31,7.943
.:/67/ /00/-87
00/3 .425.,9438
-
8/14/2019 Lecture 19 - Anticoagulants
40/43
$$$ "%#
%080 3.:/0
.4403,80 3-9478 ,8573 09.
%0 ,70 :80/ 3 :389,-0 ,33, ,3/
24.,7/, 31,7.943
-
8/14/2019 Lecture 19 - Anticoagulants
41/43
3-9478 41 ! 70.05947 ,.9;9 09.45/30 .45/470
! 70.05947 ,.9;,943 8 30,9;0 .4:50/
94 ,/03 ..,80 %0 ,70 :80/ 3 :389,-0
,33, ,3/ 3 5,90398 9 97,38039 8.,02.
,99,.8 %.45/30 8 8:9,-0 3 5,90398 4
.,3349 9407,90 ,8573
-
8/14/2019 Lecture 19 - Anticoagulants
42/43
57/,240.4743,7;,84/,947
93-985,900954854/08907,80,.9;9
9,843-98839088419742-4,308,3/549039,90900110.94157489,..3
097,3 3-985,90091:3.943,3/
1-7354207,943
-
8/14/2019 Lecture 19 - Anticoagulants
43/43
4,:,943,8.,/0